Background: Hepatitis C (HCV) and diabetes mellitus (DM) are major health burden with
Introduction
Hepatitis C virus (HCV) is a RNA virus that infects more than 150 million people all over the world. It is a global burden on health resources.
There are various routes of infection e.g. addiction, recipients of infected blood products, etc. HCV has 6 genotypes that differ in the geographical distribution and response to antiviral therapy (1, 2) .
In fact HCV is not a simple infection in which the virus lives in the liver with local effects only.
Actually it is a systemic or multi facet disease in which it affects the liver causing liver fibrosis that progress to cirrhosis, decompensating and ultimately hepatocellular carcinoma. 373.41 ±50.98pg/ml; p=0.001) (Table1, Figure 3 ).
The comparison between DM-related macroalbuminuria negative and positive for HCV association showed that control and the studies patients were matched for age and sex ( figure 3 ). In this study we tried to find that the HCV infection increases the burden over the kidney in diabetic patients. Moreover, we tried to assess the role of TNF, hs-CRP and IL-18 in such condition.
Abdel Aziz et al., (25) studied the impact of HCV infection on the microvascular complications in diabetic patients (25) . Patients with chronic HCV had higher serum cholesterol, triglycerides.,HbA1c
and urinary albumin excretion.
In the current study TNF was not useful for 12. Mora C, Navarro JF . Inflammation and pathogenesis of diabetic nephropathy.
